Press Releases

2018

Flagship Pioneering and its portfolio companies make news because of their transformative approaches to solving global challenges. If you have needs beyond these resources, please contact press@flagshippioneering.com.

company

year

domain

Rubius Therapeutics, Inc. Secures $75 Million Loan Facility

12.21.2018

Foghorn® Therapeutics Appoints Carl P. Decicco, Ph.D. as Chief Scientific Officer

Foghorn Therapeutics, Flagship Pioneering 12.13.2018

Indigo Ag, Inc. Acquires TellusLabs, a Leader in Satellite Technology and Artificial Intelligence, to Enhance Indigo’s Data-Driven Agronomic Solutions

Indigo Agriculture 12.13.2018

Denali Therapeutics Announces First Patient Dosed In Phase 1b Study Of DNL201 For Parkinson’s Disease

Denali Therapeutics 12.10.2018

Evelo Enters into Clinical Trial Collaboration Agreement with Merck

Evelo Biosciences 11.27.2018

Evelo Biosciences Announces First Dosing in Phase 1b Clinical Trial of EDP1815 in Psoriasis and Atopic Dermatitis

Evelo Biosciences 11.26.2018

Denali Therapeutics Announces Positive Clinical Results With Its Lead RIPK1 Inhibitor Molecule And Intention To Initiate Patient Studies In Multiple Indications In Collaboration With Sanofi

Denali Therapeutics 11.19.2018

Syros Announces Dose Escalation Data from Phase 1 Trial of SY-1365 Demonstrating Proof-of-Mechanism at Tolerable Doses in Patients with Advanced Solid Tumors

Syros Pharmaceuticals 11.15.2018

Flagship Pioneering Names Ryan Watts, CEO of Denali Therapeutics, as Recipient of the 2018 Pioneering Leader Award

Flagship Pioneering, Denali Therapeutics 11.15.2018

Sigilon Therapeutics Announces Appointment of Four New Members of Senior Management Team

Sigilon Therapeutics 11.13.2018

Loading